Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transferrin receptor targeting chimeras for membrane protein degradation
Dingpeng Zhang, Jhoely Duque-Jimenez, Francesco Facchinetti, et al.
Nature (2024)
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
Youmei Xiao, Zhuoying He, Wanqiong Li, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Cancer Specific CAIX‐Targeting Supramolecular Lysosome‐Targeting Chimeras (Supra‐LYTAC) for Targeted Protein Degradation
Do‐Hyun Kim, Gyeongseok Yang, Chaelyeong Lim, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
TransTACs: Transforming antibodies into targeted protein degraders
Yu Guo, Jinxin Che, Xiaowu Dong
Acta Pharmaceutica Sinica B (2025) Vol. 15, Iss. 2, pp. 1186-1188
Open Access
Genetically-encoded targeted protein degradation technology to remove endogenous condensation-prone proteins and improve crop performance
Ming Luo, Sitao Zhu, Hua Dang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
PROTAC technology for prostate cancer treatment
Zhen Wang, Dingpeng Zhang, Hiroyuki Inuzuka, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 1
Open Access
Biomembrane structure at the molecular level and its application in precision medicine
Z.Q. Wang, Zhiyuan Tian, Jing Gao, et al.
Biophysics Reviews (2025) Vol. 6, Iss. 1
Closed Access
Lysosome-Targeting Chimera Using Mannose-6-Phosphate Glycans Derived from Glyco-Engineered Yeast
Seobin Kim, Jiyeon Kang, D.R. An, et al.
Bioconjugate Chemistry (2025)
Closed Access
Editorial: The potential of transferrin as a drug target and drug delivery system
Patrícia Carrilho, Sidharth Chopra, Mallikarjuna Rao Pichika, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Multivalent DNA lysosome-targeting chimaera for targeted protein degradation and inhibition of c-Met signaling pathways
Xinhuan Chen, Mengmeng Ji, Xue Bai, et al.
Chemical Engineering Journal (2025), pp. 161974-161974
Closed Access
USP28-Based Deubiquitinase-Targeting Chimeras for Cancer Treatment
Zhen Wang, C. D. Qian, Yan Xiong, et al.
Journal of the American Chemical Society (2025)
Closed Access
SETD1B promotes brain cell ferroptosis in ischemic stroke mice via increasing H3K4me3 enrichment on the Tfrc promoter
Li Wang, Hongrui Liu, Huiqi Liu, et al.
Life Sciences (2025) Vol. 372, pp. 123625-123625
Closed Access
Sortilin‐Mediated Rapid, Precise and Sustained Degradation of Membrane Proteins via mRNA‐Encoded Lysosome‐Targeting Chimera
Xin Chang, Xinyu Qiu, Tong Xiang, et al.
Advanced Science (2025)
Open Access
Targeted degradation of extracellular proteins: state of the art and diversity of degrader designs
Md. Abdullah Al Mamun, Anush Bakunts, Alexander Chernorudskiy
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Staudinger Reaction-Responsive Coacervates for Cytosolic Antibody Delivery and TRIM21-Mediated Protein Degradation
Yishu Bao, Zhiyi Xu, Kai Cheng, et al.
Journal of the American Chemical Society (2025)
Closed Access
Dual modified ferritin nanocages for tumor-targeted and microenvironment-responsive drug delivery
Hanlin Li, Yuhan Qu, Zhanzhi Guo, et al.
International Journal of Biological Macromolecules (2025) Vol. 303, pp. 140694-140694
Closed Access
Matchmaking at the cell surface using bispecifics to put cells on their best behavior
C. Driscoll, Mark Howarth
Current Opinion in Biotechnology (2025) Vol. 92, pp. 103267-103267
Open Access
Bioengineered ferritin-based LYTAC platform for tumor-targeted therapy
Kelong Fan, Shuai Zhang, Yiliang Jin, et al.
Research Square (Research Square) (2025)
Closed Access
Induced proximity at the cell surface
Nicholas A. Till, Muthukumar Ramanathan, Carolyn R. Bertozzi
Nature Biotechnology (2025)
Closed Access
Targeting neurodegenerative disease-associated protein aggregation with proximity-inducing modalities
Ruixin Ge, Miao Chen, Qingchao Li, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Targeted protein degradation for cancer therapy
Matthias Hinterndorfer, Valentina A. Spiteri, Alessio Ciulli, et al.
Nature reviews. Cancer (2025)
Closed Access
Recent advances in degraders engaging lysosomal pathways and related nanomedicine
Runxin Lu, Xiaofeng Ni, Sha Diao, et al.
European Journal of Medicinal Chemistry (2025), pp. 117701-117701
Closed Access
Advances in DNA-empowered membrane surface engineering for artificial manipulation and visual analysis of cell-cell communication
Tian Zhang, Xun Guo, Jiao Zheng, et al.
TrAC Trends in Analytical Chemistry (2025), pp. 118280-118280
Closed Access
IGF2 Peptide-Based LYTACs for Targeted Degradation of Extracellular and Transmembrane Proteins
Michał Mikitiuk, Jan Barczyński, Przemysław Bielski, et al.
Molecules (2023) Vol. 28, Iss. 22, pp. 7519-7519
Open Access | Times Cited: 7
Directed Evolution of Genetically Encoded LYTACs for Cell-Mediated Delivery
Jonathan Lee Yang, Sean A. Yamada‐Hunter, Louai Labanieh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Targeted degradation of endogenous condensation-prone proteins improves crop performance
Ming Luo, Qing Wen, Sitao Zhu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top